Shares of DexCom (NASDAQ: DXCM) surged higher on Monday, gaining as much as 5.3%. The catalyst that sent the medical device maker higher was bullish commentary by one Wall Street analyst. Leerink analysts initiated coverage of DexCom with an outperform rating, while simultaneously assigning a $110 price target, according to The Fly.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles